CompletedPhase 2NCT03537495

Pharmacokinetic Study of Linezolid for TB Meningitis

Studying Tuberculosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Universitas Padjadjaran
Principal Investigator
Ahmad R Ganiem, MD, PhD
Hasan Sadikin General Hospital, Bandung, Indonesia
Intervention
Linezolid(drug)
Enrollment
36 enrolled
Eligibility
18 years · All sexes
Timeline
20212023

Study locations (1)

Collaborators

Radboud University Medical Center · Global Alliance for TB Drug Development

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03537495 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis

← Back to all trials